GLP1R and type 2 diabetes mellitus: In a similar analysis conducted in T2DM initiating GLP-1 RA treatment in 2013, Divino and colleagues [16] examined treatment patterns with exBID, exQW, LIRA and LIXI over 1 year from initiation in five European countries.